Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

Personetics secures a $75 million investment from Warburg Pincus to accelerate the global expansion of its AI-driven personalization and engagement solutions for financial institutions

Published

on

 

Personetics, the leading global provider of data-driven personalization and customer engagement solutions for banks and financial services providers, today announced it has raised $75m in growth funding from Warburg Pincus LLC, a leading global private equity firm focused on growth investing. Personetics is backed by Viola Ventures, Lightspeed Ventures, Sequoia Capital and Nyca Partners. Terms of the transaction were not disclosed.

Personetics offers a proprietary AI software platform to leading banks around the world. Its software touches more than 95 million personal banking customers and analyzes billions of transactions daily. Personetics analyses customer financial data and behavior in real-time, with the data staying safely inside the bank’s ecosystem so that confidentiality is guaranteed.

Banks use Personetics’ agile tools and its low-code Engagement Builder, a Creation & Management Console, to quickly modify hundreds of pre-programmed insights and build customized user journeys. This empowers banks to share real-time personalized insights and advice, as well as automated, self-adjustable financial wellness programs across its customer base comprising both individual banking customers and small businesses.

Financial institutions increasingly recognize the importance of value-driven and proactive digital engagement with their customers and must offer exceptional customer service to retain customer loyalty, whilst exploring ways to monetize these relationships. Operating in a global market worth circa $13 billion, Personetics’ business solutions have become the global market standard and are successfully delivering the vision of ‘self-driving finance’.

The benefits and ROI of providing data-driven, hyper-personalized, engagement to every customer interaction are immediate and substantial. Banks using the Personetics AI software are seeing an up to 35% increase in digital customer engagement, a 20% increase in an account and balance growth and a 15% increase in the adoption of personalized product recommendations and advice.

Flagship clients include many of the worlds leading banks, such as U.S. Bank (US), RBC (Canada), Intesa Sanpaolo (Italy), Santander (Spain), KBC (Belgium), Metro Bank (UK), UOB (Singapore), Hyundai Card (Korea) and MUFG (Japan).

David Sosna, CEO and Co-Founder of Personetics, said:
“The financial services industry is reaching a tipping–point in mobile adoption and setting a new standard in Smart Personalized Engagement. Personetics has set out down this path and has launched its vision of Self-Driving Finance.  We are looking to quickly expand our global footprint with new partners and clients, and support our existing customers with innovative business solutions. We are very excited to be partnering with Warburg Pincus on this journey.”

Peter Deming, Managing Director at Warburg Pincus and Head of Financial Services across EMEA, said: “Personetics leverages an unrivaled AI technology which is badly needed by established banks as they seek to differentiate themselves in a crowded market and match the customer experience of the Neobanks and FinTech apps. David and his team have built the perfect solution for the post-COVID banking distribution model and already secured a world-class client base. Through the combination of our financial backing and Warburg Pincus’ extensive global network across financial services, Personetics can distribute its unique technology into banks all over the world.”

Adarsh Sarma, Co-Head of Europe at Warburg Pincus, said: “Israel continues to offer innovative, high growth investment opportunities across technology, financial technology and financial services, all sectors of particular interest to Warburg Pincus. We have committed almost $700 million of equity to businesses in Israel since our founding which is a testament to the talent and innovation that the country has fostered.  In spite of the global pandemic, Israel is very much open for business and we look forward to a fruitful and successful partnership with Personetics.”

Avi Zeevi, Co-founder of Viola Ventures and Personetics’ Chairman, said: “We are happy to join forces with Warburg Pincus, a renowned international investor with an extensive global network and track record of success in the financial services and FinTech sectors. This is further proof of Israel’s ability to generate leading global FinTech companies and for Personetics’ immense potential for disruption across the global banking ecosystem.”

Fintech PR

Announcement of change in the total number of votes in AB SKF

Published

on

announcement-of-change-in-the-total-number-of-votes-in-ab-skf

GOTHENBURG, Sweden, March 28, 2024 /PRNewswire/ — Due to a conversion of shares from Series A to Series B in accordance with AB SKF’s Articles of Association, the Company confirms the following.

As per 28 March 2024, the Company’s share capital amounts to SEK 1,138,377,670 and the total number of shares amounts to 29,286,933 shares of Series A and 426,064,135 shares of Series B. The number of votes in the Company amounts to 71,893,346.5.

AB SKF does not hold any own shares.

Aktiebolaget SKF
      (publ)

Information in this press release contains information that AB SKF is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication on 28 March 2024 at 08.00 CET.

CONTACT:

For further information, please contact:
PRESS: Carl Bjernstam, Head of Media Relations
tel: 46 31-337 2517; mobile: 46 722-201 893; e-mail: [email protected] 

INVESTOR RELATIONS: Sophie Arnius, Head of Investor Relations
tel: 46 31-337 8072; mobile: 46 705-908 072; [email protected]  

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skf/r/announcement-of-change-in-the-total-number-of-votes-in-ab-skf,c3953982

The following files are available for download:

https://mb.cision.com/Main/637/3953982/2702083.pdf

20240328 Announcement of change in the total number of votes in AB SKF

 

View original content:https://www.prnewswire.co.uk/news-releases/announcement-of-change-in-the-total-number-of-votes-in-ab-skf-302102292.html

Continue Reading

Fintech PR

Tetragon Financial Group Limited February 2024 Monthly Factsheet

Published

on

tetragon-financial-group-limited-february-2024-monthly-factsheet

LONDON, March 28, 2024 /PRNewswire/ — Tetragon has released its Monthly Factsheet for February 2024.

–  Net Asset Value: $ 2,801m
–  Fully Diluted NAV Per Share: $30.93
–  Share Price (TFG NA): $9.60
–  Monthly NAV per share total return: 0.7%
–  Monthly Return on Equity: 0.8%
–  Most recent quarterly dividend: $0.11
–  Dividend yield: 4.6%

Please refer to important disclosures on page three of the Monthly Factsheet.

Please click below to access the Monthly Factsheet.

February 2024 Factsheet 

About Tetragon:

Tetragon is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at www.tetragoninv.com.

Tetragon’s non-voting shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors.

Please see: https://www.tetragoninv.com/shareholders/additional-information.

Tetragon Investor Relations:
Yuko Thomas
[email protected]

Press Inquiries:
Prosek Partners
[email protected]
U.K. +44 20 3890 9193
U.S. +1 212 279 3115

This release does not contain or constitute an offer to sell or a solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities of Tetragon have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to U.S. persons unless they are registered under applicable law or exempt from registration. Tetragon does not intend to register any portion of its securities in the United States or to conduct a public offer of securities in the United States. In addition, Tetragon has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act. Tetragon is registered in the public register of the Netherlands Authority for the Financial Markets under Section 1:107 of the Financial Markets Supervision Act as a collective investment scheme from a designated country.    

 

View original content:https://www.prnewswire.co.uk/news-releases/tetragon-financial-group-limited-february-2024-monthly-factsheet-302101163.html

Continue Reading

Fintech PR

XRP Healthcare move forward as one entity for African M&A venture

Published

on

xrp-healthcare-move-forward-as-one-entity-for-african-m&a-venture

DUBAI, UAE, March 28, 2024 /PRNewswire/ — In a bold move to address the challenges of the highly fragmented African healthcare sector, XRP Healthcare is excited to announce the incorporation of XRP Healthcare Africa, in Uganda. This strategic decision marks a significant step towards consolidating healthcare services and streamlining operations across the continent, fostering a more unified and efficient healthcare landscape.

 

XRP Healthcare recognizing the critical need for an integrated healthcare system, has taken decisive action by establishing XRP Healthcare Africa, in Uganda – a fully autonomous entity with a compliant legal structure to operate on the African continent.

This development is a testament to XRP Healthcare’s commitment to creating a sustainable and independent operational framework in Uganda and Africa.

“Our vision for XRP Healthcare Africa is to create a robust and unified healthcare entity that can efficiently address the needs of the African population,” stated CEO/Founder Kain Roomes at XRP Healthcare. “By consolidating our mergers and acquisitions local operations under XRP Healthcare Africa, we are eliminating dependencies on third-party entities such as The Burnratty Investment Group, which will no longer be part of our plans moving forward, but rather we have opted for a fully owned entity such as XRP Healthcare Africa, ensuring a streamlined and cohesive approach towards achieving our M&A goals here in Uganda.”

The Dubai-incorporated arm of XRP Healthcare, established last year in the UAE, will be pivotal in facilitating the organization’s acquisitions across the continent. Additionally, the recent incorporation of XRP Healthcare Africa in Uganda signifies a strategic move to enhance the company’s ability to manage local transactions and operations efficiently, further solidifying its presence and commitment to improving healthcare in Africa.

“Setting up XRP Healthcare Africa in Uganda is a critical step in our strategy to deepen our engagement with local communities,” explained Laban Roomes, Business Development Officer at XRP Healthcare. “This local incorporation allows us to navigate the unique challenges and opportunities within the African healthcare sector more effectively, ensuring that our efforts are closely aligned with the needs of the communities we serve.”

Over the coming weeks and months, XRP Healthcare is poised to share updates and progress on its journey to consolidate the fragmented healthcare sector in Uganda and beyond. This initiative underscores the organization’s dedication to raising funds independently and leveraging its consolidated structure to drive significant improvements in healthcare access, quality, and efficiency across Africa.

“We are thrilled to be streamlining and developing our local operations, now bolstered by an independent legal framework fully aligned with Uganda’s legal system,” said Chairman Whitney Lynn, who has over 45 years of experience in the M&A sector expressed his enthusiasm for the strategic direction of XRP Healthcare and the incorporation of XRP Healthcare Africa, in Uganda.

“The establishment of a cohesive and autonomous entity in Uganda marks a significant milestone in our journey. I’m incredibly excited about the opportunity to reveal our plans and the progress we anticipate in Uganda. This move not only strengthens our commitment to the region but also sets the stage for a transformative impact on healthcare delivery across Africa.”

 

About XRP Healthcare

XRP Healthcare is the first Pharma and Healthcare platform on the XRP Ledger, enabling fast global payments, improving healthcare access in emerging markets, and creating realworld utility by transforming global healthcare through mergers, acquisitions and blockchain.

 

www.xrphealthcare.com

Photo – https://mma.prnewswire.com/media/2373918/XRP_Healthcare_1.jpg
Logo – https://mma.prnewswire.com/media/2365357/XRP_Healthcare_Logo.jpg

XRP Healthcare Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/xrp-healthcare-move-forward-as-one-entity-for-african-ma-venture-302101765.html

Continue Reading

Trending